Doublelow Tablet 80/5 mg

Adult dose

The recommended dose is 1 tablet once a day, to be taken with water regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). For patients with mild to moderate renal impairment, no dose adjustment is necessary, but for those with severe impairment, treatment should start at a lower dose and gradually increase. For patients with liver impairment, the daily dose of telmisartan should not exceed 40 mg.

Child dose

Safety and efficacy in pediatric patients under 18 years of age have not been established, thus the administration of this medication is not recommended.

This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should be avoided by women who are pregnant or may become pregnant. It should not be used by patients with allergies to the active ingredients or similar components, severely impaired liver, heart, or kidney function, pregnant women, nursing mothers, and patients with certain heart diseases. Patients with primary aldosteronism, certain heart valve diseases, reduced liver function, gastrointestinal diseases, or problems with renal vasculature should use this medication with caution. Common side effects may include dizziness or peripheral edema, and while serious side effects can occur rarely, any abnormal symptoms should prompt immediate consultation with a physician. This medication should not be initiated during pregnancy, and if pregnancy is confirmed, it should be discontinued as soon as possible. It lowers blood pressure, so patients at risk of hypotension should consult their doctor before taking it. Potassium levels in the blood may increase, so particularly patients with reduced kidney function or heart failure should have their potassium levels monitored regularly. Patients with reduced kidney function should monitor their kidney function and potassium levels periodically while taking this medication, and those with heart disease should observe symptoms carefully. This medication may interact with certain other drugs, so if any other medications are being taken, the physician or pharmacist must be informed. Elderly patients may respond more sensitively to this medication, thus requiring dosage adjustments and careful monitoring. In case of overdose, symptoms such as hypotension, dizziness, and arrhythmias may appear, so immediate medical attention is necessary. This medication has not been established as safe and effective for children and is not recommended for use in this population. Keep the medication out of reach of children, take it immediately after opening, and avoid transferring it to another container.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, pain in the mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), profound fatigue, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, markedly reduced urine output

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory tract infection
• urinary tract infection
• anemia
• hyperkalemia
• hypoglycemia
• hyponatremia
• hyperglycemia
• depression

This medication should be stored in a tightly closed container protected from light and kept at a temperature between 1 and 30 degrees Celsius at room temperature. This will help maintain the drug's effectiveness and prevent deterioration.

Appearance

White or off-white rectangular tablet

Package unit

30 tablets (10 tablets/AluAlu * 3), 30 tablets/bottle